Mitochondrial Medicine

9–11 May 2018

Wellcome Genome Campus, Hinxton, UK


We are pleased to announce the third in our series of meetings on
mitochondrial disorders and the search for novel effective therapies.
Mitochondrial diseases are the largest group of inherited metabolic
disorders, and the past decade has seen major advances in our
understanding of the molecular mechanisms involved.

The year’s meeting aims to bridge the gap between our current
understanding of the mechanisms and processes that go awry in
mitochondrial disease and the novel approaches being developed to treat
them. We will also include sessions on clinical trial design and cohorts
that are trial ready. In addition, there will be a late-breaking session
focusing on new clinical intervention studies.

This conference will bring together leaders in the field of translational
mitochondrial medicine, with a programme designed to engage and inspire
the next generation of mitochondrial researchers. The meeting attracts
international participants interested in mitochondrial diseases, working
in molecular genetics, biochemistry, pathology, and clinical medicine.


The conference will start at approximately 11:30 with registration on
Wednesday 9 May and close at approximately 13.00 on Friday 11 May 2018.

Topics will include:

  • Precision diagnostics and new clinical biomarkers
  • What determines the phenotype of mitochondrial diseases?
  • Autophagy-mitophagy: is it important for mitochondrial disease?
  • Fission/fusion defects in mitochondrial disease: cause or effect?
  • Mitochondrial biogenesis: the key to therapy?
  • Gene editing to treat mitochondrial diseases
  • Clinical trials
  • Late-breaking clinical intervention studies

The final
is available.

Organisers and speakers

Scientific programme committee
Patrick Chinnery University of Cambridge, UK

Marni Falk
The Children’s Hospital of Philadelphia, USA

Vamsi Mootha
Harvard Medical School, USA 
Jan Smeitink
Radboud UMC, The Netherlands
Anu Suomalainen
University of Helsinki, Finland
Massimo Zeviani
MRC Mitochondrial Biology Unit, Cambridge,

Confirmed speakers
Ian Ganley
University of Dundee, UK
Michio Hirano Columbia University, USA
Carla Koehler
öran Larsson Karolinska
Institutet, Sweden
Haya Lorberboum-Galski
Hebrew University of Jerusalem,
David Pagliarini
University of Wisconsin-Madison, USA
Holger Prokisch
Institute of Human Genetics, Germany
Julien Prudent
MRC Mitochondrial Biology Unit, UK
Shamima Rahman
University College London, UK
Elena Rugarli
University of Cologne, Germany
Orian Shirihai
Boston University, USA
Anu Suomalainen University of Helsinki,
Rong Tian
University of Washington, USA
Patrick Yu-Wai-Man University of Cambridge,

Conference organiser
Lucy Criddle Wellcome Genome Campus, UK

How to apply


Registration Fees:

Early Bird *
(until 27 Feb)
(from 28 Feb)
Student No accommodation £274 £374
Student On site twin accommodation £376 £476
Student On site single accommodation £444 £544
Academic No accommodation £374 £474
Academic On site twin accommodation £476 £576
Academic On site single accommodation £544 £644
Commercial No accommodation £474 £574
Commercial On site twin accommodation £576 £676
Commercial On site single accommodation £644 £744

* Owing to space constraints, the Early Bird discount rate is limited to 100

The registration fee includes entrance to the lectures and poster
sessions, an abstract book, meals (lunch and dinner) and refreshments
during the conference. Breakfast will be provided for delegates who have
booked accommodation.

Registration deadlines
Early Bird registration: 13 March 2018
Standard registration: 17 April 2018

Please note onsite accommodation has now sold out.

Accommodation is provided for the nights of 9 and 10 May 2018. Please
note: there is limited onsite accommodation and this will be allocated on
a first-come, first-served basis. Therefore, early registration is

If you wish to book onsite accommodation either side of the conference
dates, please contact the Conference Centre directly.

Travel visas
Contact the conference organiser if you require a letter to support a
travel visa application. Please note: letters will only be provided to
confirmed registrants.

Non-European Economic Area or Swiss nationals may be required to have a
visa to enter the UK.
Early application is strongly advised, as this process can take 6-8 weeks
or longer.

Please visit the following websites for further information:
UK Border Agency website:

Information for general visitors and business visitors:


A limited number of registration bursaries are available for PhD students
to attend this conference (up to 50% of the standard registration fee)
from Wellcome Genome Campus Scientific Conferences.

The following documents will need to be provided:

  • Abstract
  • CV
  • Covering letter
  • Letter from supervisor

To apply, please contact the conference organiser.

Bursary deadline: Closed

Additional funding opportunities
our Funding webpage
for additional funding opportunities currently


We welcome abstracts from all areas relevant to the main themes of the
meeting, for both oral and poster presentations. Several oral
presentations will be chosen from the abstracts submitted.

Abstracts will only be considered from registered delegates. Please use our online abstract submission system and follow the instructions given to ensure your abstract is submitted correctly. All abstracts must be submitted by the deadline. If you are intending to submit more than one abstract, please contact the conference organiser prior to registration.

The scientific programme committee will assess your abstract after the
deadline has passed and you will be notified whether you have been
selected for an oral or poster presentation.

Poster boards onsite will accommodate 118 cm high by 84 cm wide (A0-
portrait) of printed material. Accepted abstracts will appear in the
conference programme book and poster boards will be allocated at the

Abstract deadline: 27 March 2018

Abstract guidelines can be viewed here.

Back to top Back to top